MedPageToday -- NEW ORLEANS -- The incidence of allergic reactions was similar among patients with hemophilia B being treated with plasma-derived factor IX and those receiving recombinant factor IX (BeneFIX), according to research presented here.
MedPageToday -- NEW ORLEANS -- The incidence of allergic reactions was similar among patients with hemophilia B being treated with plasma-derived factor IX and those receiving recombinant factor IX (BeneFIX), according to research presented here.